MedPath

Nerve Blocks vs Local Injections for Post-op Pain Prevention in Laparoscopic Cholecystectomy in Children

Not Applicable
Completed
Conditions
Laparoscopic Cholecystectomy
Registration Number
NCT03022279
Lead Sponsor
Brian Wallace Gray
Brief Summary

The objective of this study is to compare transversus abdominis plane (TAP) blocks to local wound infiltration (LWI) in terms of postoperative pain control in pediatric patients undergoing elective laparoscopic cholecystectomy. Our hypothesis is that TAP blocks will be superior to LWI for postoperative pain control resulting in decreased use of opioid / narcotic pain medication and decreased pain scored in the immediate 24-hour postoperative period. The rationale is that determining the effect of analgesia in this pediatric population is important to optimize clinical care.

Detailed Description

In this study, patients ages 8 through 17 years scheduled for elective laparoscopic cholecystectomy will be invited to participate. Those having da Vinci cholecystectomy procedures will also be eligible. The da Vinci System is a minimally invasive option utilizing robotic technology. Once randomized, the patient will undergo either ultrasound guided bilateral TAP blocks or LWI at the beginning of the surgical procedure. Prospective data regarding pain scores, use of opioid medication, and nausea and vomiting episodes will be collected for both groups. Due to the nature of the study, it will not be possible to blind the investigators to the randomly selected method of injecting local anesthesia; however the personnel involved in the post-anesthetic and post-operative assessment will be blinded to the intervention, as well as the subjects themselves.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
87
Inclusion Criteria
  1. 8-17 yrs of age at date of enrollment.
  2. Elective laparoscopic or da Vinci cholecystectomy scheduled for any diagnostic reason.
Exclusion Criteria
  1. Chronic pain or chronic use of narcotic or other prescription pain medications.
  2. Use of pain medication within 24 hours before surgery
  3. Prior major abdominal surgery
  4. Evidence of acute inflammation
  5. Patients with acute cholecystitis
  6. Bleeding / coagulation disorder
  7. Seizure disorder
  8. Renal dysfunction
  9. Infection at injection sites for TAP block or trocar placement
  10. Contraindication to LWI or TAP block procedure, as determined by surgeon or anesthesiologist performing the procedure (including, but not limited to, previous incision distorting anatomy or inability to visualize anatomical planes)
  11. Any known allergy to medications used in this study
  12. Patient unable to verbalize pain score or independently assess pain level
  13. Unstable patient in need of emergent intervention at surgeon discretion
  14. Patients who are known to be pregnant
  15. Patients who are currently prisoners
  16. Children in custody of the state
  17. Subjects will a BMI >/= 50
  18. Investigator discretion for any other reason

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Amount of narcotic pain medication24 hours post-op
Time to first request of pain medicationFrom post-anesthesia care unit "(PACU) in" time to first pain medication dose, up to 24 hours
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Riley Hospital for Children at IU Health

🇺🇸

Indianapolis, Indiana, United States

Riley Hospital for Children at IU Health
🇺🇸Indianapolis, Indiana, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.